These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37682820)

  • 41. Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients.
    Zheng R; Zhu C; Guo Q; Qin L; Wang J; Lu J; Cui H; Cui Z; Ge B; Liu J; Hu Z
    BMC Infect Dis; 2014 Apr; 14():200. PubMed ID: 24725975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    Mekonnen B; Mihret A; Getahun M; Hailu T; Sidiki S; V Kelley H; Scordo JM; Hunt WG; Pan X; Balada-Llasat JM; Gebreyes W; Evans CA; Aseffa A; Torrelles JB; Wang SH; Abebe T
    PLoS One; 2019; 14(5):e0215679. PubMed ID: 31136575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug sensitivity of clinical isolates of
    Worku G; Gumi B; Girma M; Mohammedbirhan B; Diriba G; Seid G; Getu M; Amare M; Sinshaw W; Ashagre W; Tschopp R; Carruth L; Ameni G
    Front Public Health; 2022; 10():942618. PubMed ID: 36062084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Getahun M; Blumberg HM; Ameni G; Beyene D; Kempker RR
    PLoS One; 2022; 17(9):e0274426. PubMed ID: 36099255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal.
    Khadka JB; Rai SK; Shrestha S; Maharjan B; Bhatta DR; Ghimire P
    Nepal Med Coll J; 2011 Sep; 13(3):147-51. PubMed ID: 22808802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
    Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical implications of discrepant results between genotypic MTBDR
    Kang JY; Hur J; Kim S; Jeon S; Lee J; Kim YJ; Kim SC; Park YJ; Kim YK; Moon HS
    J Thorac Dis; 2019 Feb; 11(2):400-409. PubMed ID: 30962983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.
    Ocheretina O; Escuyer VE; Mabou MM; Royal-Mardi G; Collins S; Vilbrun SC; Pape JW; Fitzgerald DW
    PLoS One; 2014; 9(3):e90569. PubMed ID: 24599230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of genotype MTBDRplus assay for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates from Pakistan.
    Javed H; Jamil N; Jagielski T; Bakuła Z; Tahir Z
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S147-S148. PubMed ID: 28043516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of the performance of InnowaveDX MTB/RIF for the detection of
    Wang YP; Tan YH; Li X; Wang J; Chen CG; Xu J; Xiang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):658-663. PubMed ID: 37402655
    [No Abstract]   [Full Text] [Related]  

  • 52. Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.
    Nwofor AC; Nyamngee A; Nwabuisi C; Iwakun M; Gidado M; Mensah C; Dakum P; Agbede OO; Ndembi N; Blattner WA; Abimiku AG
    Curr HIV Res; 2015; 13(4):308-14. PubMed ID: 25845392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abdella K; Kebede W; Abdissa K; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):185-91. PubMed ID: 27242230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
    Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
    Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates from Sputum Samples by High-Resolution Melting Analysis.
    Parsa S; Yaghoubi A; Izadi N; Sabet F; Nik LB; Derakhshan M; Rezaee SA; Meshkat Z; Hoseini SJ; Jmehdar SA; Kiani F; Samiei A; Soleimanpour S
    Curr Microbiol; 2022 Jul; 79(9):257. PubMed ID: 35852629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
    Ogari CO; Nyamache AK; Nonoh J; Amukoye E
    BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
    Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
    Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
    Biadglegne F; Mulu A; Rodloff AC; Sack U
    Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.